- Multimodality Imaging in Pericardial Diseases and the Role of Imaging . . .
Conclusion The spectrum of pericardial disorders encompasses pericardial inflammation, effusion, constriction, and masses (Table 1)
- Anti-Inflammatory Agents for Malignant Pericardial Effusion
In active cancer patients with malignant pericardial effusion requiring drainage, what is the effect of colchicine and other anti-inflammatory agents on long-term outcomes after pericardiocentesis?
- 2015 ESC Guidelines for Pericardial Disease
Colchicine (0 5 mg daily [<70 kg] or BID [≥70 kg] for 3 months) is recommended as first-line therapy as an adjunct to aspirin NSAID therapy Incessant, recurrent, and chronic pericarditis Incessant pericarditis lasts for >4-6 weeks, but <3 months without remission
- Management of Acute and Recurrent Pericarditis
In addition, a 3-month course of colchicine (with weight-adjusted dosing) is recommended to reduce the risk of recurrent pericarditis Strenuous activity should be avoided Corticosteroids have been associated with a more prolonged disease course and a higher risk of recurrence
- Idiopathic Pericarditis - American College of Cardiology
Colchicine, in combination with aspirin nonsteroidal anti-inflammatory drugs (NSAIDs), is first-line pharmacotherapy for acute and recurrent idiopathic pericarditis
- New Concise Clinical Guidance Addresses Evaluation and Management of . . .
In terms of management, colchicine and NSAIDs (or aspirin) are recommended as first-line for acute and first recurrence of pericarditis, along with exercise restriction
- The Role of Colchicine in Recent Clinical Trials - American College of . . .
The COPE (COlchicine for acute PEricarditis) prospective, randomized, open-label trial, which included patients with a first episode of acute pericarditis, showed that colchicine, in addition to conventional anti-inflammatory therapy, significantly reduced symptoms at 72 hours (11 7% vs 36 7%; p=0 003) 1 In addition, the recurrences of
- The Paradigm Shift in the Management of Recurrent Pericarditis
Non-steroidal anti-inflammatory drugs (NSAIDs) combined with colchicine is first-line treatment for patients with acute or recurrent pericarditis 4 Available NSAIDs include ibuprofen, indomethacin, and aspirin, which is preferred in patients with concomitant cardiovascular disease
|